Potential for Novel Therapeutic Uses of Alpha Lipoic Acid

Golbidi, S.; Badran, M.; Laher, I. Diabetes and alpha lipoic Acid. Front. Pharmacol., 2011, 2, 69.
[http://dx.doi.org/10.3389/fphar.2011.00069] [PMID: 22125537]

Reed, L.J. From lipoic acid to multi-enzyme complexes. Protein Sci., 1998, 7(1), 220-224.
[http://dx.doi.org/10.1002/pro.5560070125] [PMID: 9514279]

Shay, K.P.; Moreau, R.F.; Smith, E.J.; Smith, A.R.; Hagen, T.M. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta, Gen. Subj., 2009, 1790(10), 1149-1160.
[http://dx.doi.org/10.1016/j.bbagen.2009.07.026] [PMID: 19664690]

Snell, E.E.; Strong, F.M.; Peterson, W.H. Growth factors for bacteria. Biochem. J., 1937, 31(10), 1789-1799.
[http://dx.doi.org/10.1042/bj0311789] [PMID: 16746518]

Reed, L.J.; DeBusk, B.G.; Gunsalus, I.C.; Hornberger, C.S., Jr. Crystalline alpha-lipoic acid: A catalytic agent associated with pyruvate dehydrogenase. Science, 1951, 114(2952), 93-94.
[http://dx.doi.org/10.1126/science.114.2952.93] [PMID: 14854913]

Rezaei Zonooz, S.; Hasani, M.; Morvaridzadeh, M.; Beatriz Pizarro, A.; Heydari, H.; Yosaee, S.; Rezamand, G.; Heshmati, J. Effect of alpha-lipoic acid on oxidative stress parameters: A systematic review and meta-analysis. J. Funct. Foods, 2021, 87, 104774.
[http://dx.doi.org/10.1016/j.jff.2021.104774]

Shichiri, M. The role of lipid peroxidation in neurological disorders. J. Clin. Biochem. Nutr., 2014, 54(3), 151-160.
[http://dx.doi.org/10.3164/jcbn.14-10] [PMID: 24895477]

Li, D.W.; Wang, Y.D.; Zhou, S.Y.; Sun, W.P. α-lipoic acid exerts neuroprotective effects on neuronal cells by upregulating the expression of PCNA via the P53 pathway in neurodegenerative conditions. Mol. Med. Rep., 2016, 14(5), 4360-4366.
[http://dx.doi.org/10.3892/mmr.2016.5754] [PMID: 27665784]

Liu, D.; Xu, Y. p53, oxidative stress, and aging. Antioxid. Redox Signal., 2011, 15(6), 1669-1678.
[http://dx.doi.org/10.1089/ars.2010.3644] [PMID: 21050134]

Halliwell, B. Oxidants and human disease: Some new concepts. FASEB J., 1987, 1(5), 358-364.
[http://dx.doi.org/10.1096/fasebj.1.5.2824268] [PMID: 2824268]

Mariani, R.; Trombini, P.; Pozzi, M.; Piperno, A. Iron metabolism in thalassemia and sickle cell disease. Mediterr. J. Hematol. Infect. Dis., 2009, 1(1), e2009006.
[http://dx.doi.org/10.4084/MJHID.2009.006] [PMID: 21415988]

Fung, E.B.; Harmatz, P.; Milet, M.; Ballas, S.K.; De Castro, L.; Hagar, W.; Owen, W.; Olivieri, N.; Smith-Whitley, K.; Darbari, D.; Wang, W.; Vichinsky, E. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am. J. Hematol., 2007, 82(4), 255-265.
[http://dx.doi.org/10.1002/ajh.20809] [PMID: 17094096]

Jozefczak, M.; Remans, T.; Vangronsveld, J.; Cuypers, A. Glutathione is a key player in metal-induced oxidative stress defenses. Int. J. Mol. Sci., 2012, 13(3), 3145-3175.
[http://dx.doi.org/10.3390/ijms13033145] [PMID: 22489146]

Suh, J.H.; Moreau, R.; Heath, S.H.D.; Hagen, T.M. Dietary supplementation with ( R )-α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep., 2005, 10(1), 52-60.
[http://dx.doi.org/10.1179/135100005X21624] [PMID: 15829111]

Patrick, L. Mercury toxicity and antioxidants: Part 1: Role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity. Altern. Med. Rev., 2002, 7(6), 456-471.
[PMID: 12495372]

Gerthoffer, W.T.; Singer, C.A. MAPK regulation of gene expression in airway smooth muscle. Respir. Physiol. Neurobiol., 2003, 137(2-3), 237-250.
[http://dx.doi.org/10.1016/S1569-9048(03)00150-2] [PMID: 14516729]

Hedges, J.C.; Singer, C.A.; Gerthoffer, W.T. Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. Am. J. Respir. Cell Mol. Biol., 2000, 23(1), 86-94.
[http://dx.doi.org/10.1165/ajrcmb.23.1.4014] [PMID: 10873157]

Singer, C.A.; Baker, K.J.; McCaffrey, A.; AuCoin, D.P.; Dechert, M.A.; Gerthoffer, W.T. p38 MAPK and NF-κB mediate COX-2 expression in human airway myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol., 2003, 285(5), L1087-L1098.
[http://dx.doi.org/10.1152/ajplung.00409.2002] [PMID: 12871860]

Moini, H.; Tirosh, O.; Park, Y.C.; Cho, K.J.; Packer, L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch. Biochem. Biophys., 2002, 397(2), 384-391.
[http://dx.doi.org/10.1006/abbi.2001.2680] [PMID: 11795898]

Smith, A.R.; Shenvi, S.V.; Widlansky, M.; Suh, J.H.; Hagen, T.M. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem., 2004, 11(9), 1135-1146.
[http://dx.doi.org/10.2174/0929867043365387] [PMID: 15134511]

Román-Pintos, L.M.; Villegas-Rivera, G.; Rodríguez-Carrizalez, A.D.; Miranda-Díaz, A.G.; Cardona-Muñoz, E.G. Diabetic polyneuropathy in type 2 diabetes mellitus: Inflammation, oxidative stress, and mitochondrial function. J. Diabetes Res., 2016, 2016, 3425617.
[http://dx.doi.org/10.1155/2016/3425617] [PMID: 28058263]

Packer, L.; Kraemer, K.; Rimbach, G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition, 2001, 17(10), 888-895.
[http://dx.doi.org/10.1016/S0899-9007(01)00658-X] [PMID: 11684397]

Bierhaus, A.; Chevion, S.; Chevion, M.; Hofmann, M.; Quehenberger, P.; Illmer, T.; Luther, T.; Berentshtein, E.; Tritschler, H.; Müller, M.; Wahl, P.; Ziegler, R.; Nawroth, P.P. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes, 1997, 46(9), 1481-1490.
[http://dx.doi.org/10.2337/diab.46.9.1481] [PMID: 9287050]

Moura, F.; de Andrade, K.; Farias dos Santos, J.; Fonseca Goulart, M. Lipoic Acid: Its antioxidant and anti-inflammatory role and clinical applications. Curr. Top. Med. Chem., 2015, 15(5), 458-483.
[http://dx.doi.org/10.2174/1568026615666150114161358] [PMID: 25620240]

Pilar Valdecantos, M.; Prieto-Hontoria, P.L.; Pardo, V.; Módol, T.; Santamaría, B.; Weber, M.; Herrero, L.; Serra, D.; Muntané, J.; Cuadrado, A.; Moreno-Aliaga, M.J.; Alfredo Martínez, J.; Valverde, Á.M. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes. Free Radic. Biol. Med., 2015, 84, 263-278.
[http://dx.doi.org/10.1016/j.freeradbiomed.2015.03.019] [PMID: 25841776]

Wollin, S.D.; Jones, P.J.H. Alpha-lipoic acid and cardiovascular disease. J. Nutr., 2003, 133(11), 3327-3330.
[http://dx.doi.org/10.1093/jn/133.11.3327] [PMID: 14608040]

Dünschede, F.; Erbes, K.; Kircher, A.; Westermann, S.; Seifert, J.; Schad, A.; Oliver, K.; Kiemer, A.K.; Theodor, J. Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by α-lipoic acid in humans. World J. Gastroenterol., 2006, 12(42), 6812-6817.
[http://dx.doi.org/10.3748/wjg.v12.i42.6812] [PMID: 17106930]

Ambrosi, N.; Arrosagaray, V.; Guerrieri, D.; Uva, P.D.; Petroni, J.; Herrera, M.B.; Iovanna, J.L.; León, L.; Incardona, C.; Eduardo Chuluyan, H.; Casadei, D.H. α-Lipoic acid protects against ischemia-reperfusion injury in simultaneous kidney-pancreas transplantation. Transplantation, 2016, 100(4), 908-915.
[http://dx.doi.org/10.1097/TP.0000000000000981] [PMID: 26502371]

Casciato, P.; Ambrosi, N.; Caro, F.; Vazquez, M.; Müllen, E.; Gadano, A.; de Santibañes, E.; de Santibañes, M.; Zandomeni, M.; Chahdi, M.; Lazarte, J.C.; Biagiola, D.A.; Iaquinandi, J.C.; Santofimia-Castaño, P.; Iovanna, J.; Incardona, C.; Chuluyan, E. α-lipoic acid reduces postreperfusion syndrome in human liver transplantation - a pilot study. Transpl. Int., 2018, 31(12), 1357-1368.
[http://dx.doi.org/10.1111/tri.13314] [PMID: 29974521]

Liakopoulos, V.; Roumeliotis, S.; Zarogiannis, S.; Eleftheriadis, T.; Mertens, P.R. Oxidative stress in hemodialysis: Causative mechanisms, clinical implications, and possible therapeutic interventions. Semin. Dial., 2019, 32(1), 58-71.
[http://dx.doi.org/10.1111/sdi.12745] [PMID: 30288786]

Khabbazi, T.; Mahdavi, R.; Safa, J.; Pour-Abdollahi, P. Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J. Ren. Nutr., 2012, 22(2), 244-250.
[http://dx.doi.org/10.1053/j.jrn.2011.06.005] [PMID: 21908204]

Safa, J.; Ardalan, M.R.; Rezazadehsaatlou, M.; Mesgari, M.; Mahdavi, R.; Jadid, M.P. Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis. Int. Urol. Nephrol., 2014, 46(8), 1633-1638.
[http://dx.doi.org/10.1007/s11255-014-0688-z] [PMID: 24729102]

Sydow, K.; Münzel, T. ADMA and oxidative stress. Atheroscler. Suppl., 2003, 4(4), 41-51.
[http://dx.doi.org/10.1016/S1567-5688(03)00033-3] [PMID: 14664902]

El-Nakib, G.; Mostafa, T.; Abbas, T.; El-Shishtawy, M.; Mabrouk, M.; Sobh, M. Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis. Int. J. Nephrol. Renovasc. Dis., 2013, 6, 161-168.
[http://dx.doi.org/10.2147/IJNRD.S49066] [PMID: 24023521]

Ahmadi, A.; Mazooji, N.; Roozbeh, J.; Mazloom, Z.; Hasanzade, J. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients. Iran. J. Kidney Dis., 2013, 7(6), 461-467.
[PMID: 24241092]

Himmelfarb, J.; Ikizler, T.A.; Ellis, C.; Wu, P.; Shintani, A.; Dalal, S.; Kaplan, M.; Chonchol, M.; Hakim, R.M. Provision of antioxidant therapy in hemodialysis (PATH): A randomized clinical trial. J. Am. Soc. Nephrol., 2014, 25(3), 623-633.
[http://dx.doi.org/10.1681/ASN.2013050545] [PMID: 24371300]

Vasdev, S.; Ann Ford, C.; Parai, S.; Longerich, L.; Gadag, V. Dietary α-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J. Hypertens., 2000, 18(5), 567-573.
[http://dx.doi.org/10.1097/00004872-200018050-00009] [PMID: 10826559]

Mohammadi, V.; Khalili, M.; Eghtesadi, S.; Dehghani, S.; Jazayeri, S.; Aghababaee, S.K.; Sabour, H.; Saberi, H.; Eghtesadi, M.; Gohari, M.R. The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: A clinical trial. Spinal Cord, 2015, 53(8), 621-624.
[http://dx.doi.org/10.1038/sc.2015.35] [PMID: 25753493]

Jamshidi, K.; Abdollahzad, H.; Nachvak, M.; Rezaei, M.; Golpayegani, M.R.; Sharifi Zahabi, E. Effects of alpha-lipoic acid supplementation on cardiovascular disease risk factors in β-thalassemia major patients: A clinical trial crossover study. J. Blood Med., 2020, 11, 131-139.
[http://dx.doi.org/10.2147/JBM.S252105] [PMID: 32494211]

Ng, M.; Fleming, T.; Robinson, M.; Thomson, B.; Graetz, N.; Margono, C.; Mullany, E.C.; Biryukov, S.; Abbafati, C.; Abera, S.F.; Abraham, J.P.; Abu-Rmeileh, N.M.E.; Achoki, T.; AlBuhairan, F.S.; Alemu, Z.A.; Alfonso, R.; Ali, M.K.; Ali, R.; Guzman, N.A.; Ammar, W.; Anwari, P.; Banerjee, A.; Barquera, S.; Basu, S.; Bennett, D.A.; Bhutta, Z.; Blore, J.; Cabral, N.; Nonato, I.C.; Chang, J.C.; Chowdhury, R.; Courville, K.J.; Criqui, M.H.; Cundiff, D.K.; Dabhadkar, K.C.; Dandona, L.; Davis, A.; Dayama, A.; Dharmaratne, S.D.; Ding, E.L.; Durrani, A.M.; Esteghamati, A.; Farzadfar, F.; Fay, D.F.J.; Feigin, V.L.; Flaxman, A.; Forouzanfar, M.H.; Goto, A.; Green, M.A.; Gupta, R.; Hafezi-Nejad, N.; Hankey, G.J.; Harewood, H.C.; Havmoeller, R.; Hay, S.; Hernandez, L.; Husseini, A.; Idrisov, B.T.; Ikeda, N.; Islami, F.; Jahangir, E.; Jassal, S.K.; Jee, S.H.; Jeffreys, M.; Jonas, J.B.; Kabagambe, E.K.; Khalifa, S.E.A.H.; Kengne, A.P.; Khader, Y.S.; Khang, Y.H.; Kim, D.; Kimokoti, R.W.; Kinge, J.M.; Kokubo, Y.; Kosen, S.; Kwan, G.; Lai, T.; Leinsalu, M.; Li, Y.; Liang, X.; Liu, S.; Logroscino, G.; Lotufo, P.A.; Lu, Y.; Ma, J.; Mainoo, N.K.; Mensah, G.A.; Merriman, T.R.; Mokdad, A.H.; Moschandreas, J.; Naghavi, M.; Naheed, A.; Nand, D.; Narayan, K.M.V.; Nelson, E.L.; Neuhouser, M.L.; Nisar, M.I.; Ohkubo, T.; Oti, S.O.; Pedroza, A.; Prabhakaran, D.; Roy, N.; Sampson, U.; Seo, H.; Sepanlou, S.G.; Shibuya, K.; Shiri, R.; Shiue, I.; Singh, G.M.; Singh, J.A.; Skirbekk, V.; Stapelberg, N.J.C.; Sturua, L.; Sykes, B.L.; Tobias, M.; Tran, B.X.; Trasande, L.; Toyoshima, H.; van de Vijver, S.; Vasankari, T.J.; Veerman, J.L.; Velasquez-Melendez, G.; Vlassov, V.V.; Vollset, S.E.; Vos, T.; Wang, C.; Wang, X.; Weiderpass, E.; Werdecker, A.; Wright, J.L.; Yang, Y.C.; Yatsuya, H.; Yoon, J.; Yoon, S.J.; Zhao, Y.; Zhou, M.; Zhu, S.; Lopez, A.D.; Murray, C.J.L.; Gakidou, E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2014, 384(9945), 766-781.
[http://dx.doi.org/10.1016/S0140-6736(14)60460-8] [PMID: 24880830]

Kucukgoncu, S.; Zhou, E.; Lucas, K.B.; Tek, C. Alpha-lipoic acid (ALA) as a supplementation for weight loss: Results from a meta-analysis of randomized controlled trials. Obes. Rev., 2017, 18(5), 594-601.
[http://dx.doi.org/10.1111/obr.12528] [PMID: 28295905]

Agarwal, A.; Leisegang, K.; Majzoub, A.; Adewoyin, M.; Henkel, R.; Finelli, R.; Selvam, M. K. P.; Tadros, N.; Parekh, N.; Ko, E. Y.; Cho, C. L.; Arafa, M.; Alves, M. G.; Oliveira, P. F.; Alvarez, J. G.; Shah, R. Utility of antioxidants in the treatment of male infertility: Clinical guidelines based on a systematic review and analysis of evidence. World J. Men's Health, 2021, 39(2), 233-290.
[PMID: 33474843]

Adewoyin, M.; Ibrahim, M.; Roszaman, R.; Isa, M.; Alewi, N.; Rafa, A.; Anuar, M. Male infertility: The effect of natural antioxidants and phytocompounds on seminal oxidative stress. Diseases, 2017, 5(1), 9.
[http://dx.doi.org/10.3390/diseases5010009] [PMID: 28933362]

Hodeeb, Y.M.; El-Rewiny, E.M.; Gaafar, A.M.; Zayed, A.N.; Hasan, M.S.; Elsaie, M.L. The effect of alpha lipoic acid supplementation on sperm functions in idiopathic asthenozoospermic patients: A case-controlled study. Hum. Fertil. (Camb.), 2022, 2025271.
[http://dx.doi.org/10.1080/14647273.2021.2025271] [PMID: 35023797]

Chang, J.W.; Lee, E.K.; Kim, T.H.; Min, W.K.; Chun, S.; Lee, K.U.; Kim, S.B.; Park, J.S. Effects of α-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: A pilot study. Am. J. Nephrol., 2007, 27(1), 70-74.
[http://dx.doi.org/10.1159/000099035] [PMID: 17259696]

Masharani, U.; Gjerde, C.; Evans, J.L.; Youngren, J.F.; Goldfine, I.D. Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome. J. Diabetes Sci. Technol., 2010, 4(2), 359-364.
[http://dx.doi.org/10.1177/193229681000400218] [PMID: 20307398]

Cianci, A.; Panella, M.; Fichera, M.; Falduzzi, C.; Bartolo, M.; Caruso, S. D-chiro -Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. Gynecol. Endocrinol., 2015, 31(6), 483-486.
[http://dx.doi.org/10.3109/09513590.2015.1014784] [PMID: 25893270]

Di Paolo, G.; De Camilli, P. Phosphoinositides in cell regulation and membrane dynamics. Nature, 2006, 443(7112), 651-657.
[http://dx.doi.org/10.1038/nature05185] [PMID: 17035995]

D Genazzani, A. Effects of a combination of alpha lipoic acid and myo-inositol on insulin dynamics in overweight/obese patients with PCOS. Endocrinol. Metab. Syndr., 2014, 03, 32477.

Cappelli, V.; Di Sabatino, A.; Musacchio, M.C.; De Leo, V. Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS. Minerva Ginecol., 2013, 65(4), 425-433.
[PMID: 24051942]

Rago, R.; Marcucci, I.; Leto, G.; Caponecchia, L.; Salacone, P.; Bonanni, P.; Fiori, C.; Sorrenti, G.; Sebastianelli, A. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: A pilot study. J. Biol. Regul. Homeost. Agents, 2015, 29(4), 913-923.
[PMID: 26753656]

Heinz, T.; Schuchardt, J.P.; Möller, K.; Hadji, P.; Hahn, A. Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention. Nutr. Res., 2016, 36(10), 1162-1170.
[http://dx.doi.org/10.1016/j.nutres.2016.07.005] [PMID: 27865358]

Morgante, G.; Cappelli, V.; Di Sabatino, A.; Massaro, M.G.; De Leo, V. Polycystic ovary syndrome (PCOS) and hyperandrogenism: The role of a new natural association. Minerva Ginecol., 2015, 67(5), 457-463.
[PMID: 26491824]

Becerra, J.E.; Khoury, M.J.; Cordero, J.F.; Erickson, J.D. Diabetes mellitus during pregnancy and the risks   for   specific birth defects: A   population-based   case-control   study. Pediatrics, 1990, 85(1), 1-9.
[http://dx.doi.org/10.1542/peds.85.1.1] [PMID: 2404255]

Kousseff, B.G. Diabetic embryopathy. Curr. Opin. Pediatr., 1999, 11(4), 348-352.
[http://dx.doi.org/10.1097/00008480-199908000-00014] [PMID: 10439209]

Coughlan, M.T.; Permezel, M.; Georgiou, H.M.; Rice, G.E. Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes. J. Clin. Endocrinol. Metab., 2004, 89(7), 3585-3594.
[http://dx.doi.org/10.1210/jc.2003-031953] [PMID: 15240650]

Sugimura, Y.; Murase, T.; Oyama, K.; Uchida, A.; Sato, N.; Hayasaka, S.; Kano, Y.; Takagishi, Y.; Hayashi, Y.; Oiso, Y.; Murata, Y. Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes. Diabetologia, 2009, 52(5), 962-971.
[http://dx.doi.org/10.1007/s00125-009-1312-0] [PMID: 19283362]

Di Tomo, P.; Di Silvestre, S.; Cordone, V.G.P.; Giardinelli, A.; Faricelli, B.; Pipino, C.; Lanuti, P.; Peng, T.; Formoso, G.; Yang, D.; Arduini, A.; Chiarelli, F.; Pandolfi, A.; Di Pietro, N. Centella asiatica and lipoic acid, or a combination thereof, inhibit monocyte adhesion to endothelial cells from umbilical cords of gestational diabetic women. Nutr. Metab. Cardiovasc. Dis., 2015, 25(7), 659-666.
[http://dx.doi.org/10.1016/j.numecd.2015.04.002] [PMID: 26026207]

Leite, J.; Ross, P.; Rossi, A.C.; Jeanty, P. Prognosis of very large first-trimester hematomas. J. Ultrasound Med., 2006, 25(11), 1441-1445.
[http://dx.doi.org/10.7863/jum.2006.25.11.1441] [PMID: 17060431]

Nagy, S.; Bush, M.; Stone, J.; Lapinski, R.H.; Gardó, S. Clinical significance of subchorionic and retroplacental hematomas detected   in   the   first   trimester of pregnancy. Obstet. Gynecol., 2003, 102(1), 94-100.
[PMID: 12850613]

Wang, K.C.; Tsai, C.P.; Lee, C.L.; Chen, S.Y.; Lin, G.J.; Yen,   M.H.;   Sytwu,   H.K.;   Chen,   S.J. α-Lipoic   acid   enhances   endogenous   peroxisome-proliferator-activated receptor-γ   to   ameliorate     experimental   autoimmune encephalomyelitis in mice. Clin. Sci. (Lond.), 2013, 125(7), 329-340.
[http://dx.doi.org/10.1042/CS20120560] [PMID: 23550596]

Bao, P.; Kodra, A.; Tomic-Canic, M.; Golinko, M.S.; Ehrlich, H.P.; Brem, H. The role of vascular endothelial growth factor in wound healing. J. Surg. Res., 2009, 153(2), 347-358.
[http://dx.doi.org/10.1016/j.jss.2008.04.023] [PMID: 19027922]

Micili, S.C.; Goker, A.; Sayin, O.; Akokay, P.; Ergur, B.U. The effect of lipoic acid on wound healing in a full thickness uterine injury model in rats. J. Mol. Histol., 2013, 44(3), 339-345.
[http://dx.doi.org/10.1007/s10735-013-9485-8] [PMID: 23371355]

Monastra, G.; De Grazia, S.; Cilaker Micili, S.; Goker, A.; Unfer, V. Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage. Expert Opin. Drug Deliv., 2016, 13(12), 1695-1708.
[http://dx.doi.org/10.1080/17425247.2016.1200556] [PMID: 27292272]

Porcaro, G.; Brillo, E.; Giardina, I.; Di Iorio, R. Alpha Lipoic Acid (ALA) effects on subchorionic hematoma: Preliminary clinical results. Eur. Rev. Med. Pharmacol. Sci., 2015, 19(18), 3426-3432.
[PMID: 26439038]

Costantino, M.; Guaraldi, C.; Costantino, D. Resolution of subchorionic hematoma and symptoms of threatened miscarriage using vaginal alpha lipoic acid or progesterone: Clinical evidences. Eur. Rev. Med. Pharmacol. Sci., 2016, 20(8), 1656-1663.
[PMID: 27160142]